Please login to the form below

Not currently logged in

Servier begins construction of new R&D hub in Paris

Centre to open by 2022


Servier president Olivier Laureau (centre) lays foundation for new research hub

Servier has laid the foundation stone of a new R&D hub in Paris aimed at boosting its output of novel medicines.

France’s second biggest homegrown pharma company behind Sanofi, Servier has been transforming itself in recent year by breaking away from its traditional areas of research expertise, and investing in cutting edge areas such as novel cancer candidates, including CAR-T.

Last year it paid out $2.4bn to buy Shire’s oncology division, and opened up an office in Kendall Square in Boston, Massachusetts in order to tap into new science and licensing opportunities.

Now it has committed to making the Paris-Saclay Cluster, just south of the capital, its research base in France.

The new Servier Paris-Saclay Research Institute will consolidate all of the company’s research activities in the country by 2022, sitting in a cluster home to 40% of all industrial R&D in the Paris region.

Servier’s new home will see it rub shoulders with a wide range of research ventures, with the goal of creating a natural breeding ground for life sciences collaboration, as seen in Boston’s Kendall Square, San Francisco and England’s ‘golden triangle’.

Olivier Laureau, president of Servier, said: “It is with great joy and pride to lay the foundation stone of the future Servier Paris-Saclay Research Institute, within this innovative and dynamic ecosystem. This milestone further exemplifies the group’s ongoing commitment to the discovery of innovative therapeutic solutions for patients.”

In its late-stage pipeline, Servier and partner Amgen have heart failure candidate omecamtiv mecarbil advancing towards a pivotal phase 3 trial read out.

The company was hit last year when the much-anticipated Pixuvri failed in a phase 3 trial for in non-Hodgkin’s lymphoma (NHL).

20th June 2019

From: Research



COVID-19 Updates and Daily News

Featured jobs


Add my company Events and Exhibition Stands is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...